Categories
In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes,
Categories
BioZorb Markers and Potential Risks with Use in Breast Tissue: FDA Safety Communication
FDA is informing the public of adverse events reported with the use of BioZorb Marker including pain, migration, erosion, and others.
Categories
Brassica Pharma Pvt. Ltd. Issues Voluntary Nationwide Recall of Equate Lubricant Eye Ointment, Equate Stye Lubricant Eye Ointment, CVS Health Lubricant Eye Ointment, Lubricant PM Ointment Due to Potential Lack of Sterility
Brassica Pharma Pvt. Ltd. is voluntarily recalling Eye Ointment products listed in the table below with expiration date ranging from February 2024 to September 2025. The products are being recalled due to lack of sterility assurance at the facility noted during an inspection conducted by the Food an
Categories
FDA Roundup: February 23, 2024
FDA Roundup: February 23, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-february-23-2024
Categories
Medtronic Recalls NIM CONTACT Reinforced EMG Endotracheal Tube and the NIM Standard Reinforced EMG Endotracheal Tube for Risk of Airway Obstruction
The NIM CONTACT and Standard Reinforced EMG Endotracheal Tubes may obstruct the patient’s airway.
Categories
Do Not Use Smartwatches or Smart Rings to Measure Blood Glucose Levels: FDA Safety Communication
Do not use smartwatches or smart rings to measure blood glucose. They are not authorized by the FDA. Using them could result in inaccurate blood glucose measurement, which can lead to serious injury or death if used to make medical decisions. Only use FDA-authorized devices to measure blood glucose.
Categories
Update: Recommendations for Certain Medtronic Electromyogram Endotracheal Tubes and Risk of Airway Obstruction – Letter to Health Care Providers
Medtronic initiates recall for silicone-based EMG endotracheal tubes due to the risk of airway obstruction and ventilation failure.
Categories
FDA Roundup: February 20, 2024
FDA Roundup: February 20, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-february-20-2024
Categories
FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
http://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-unresectable-or-metastatic-melanoma
Categories
FDA Roundup: February 16, 2024
FDA Roundup: February 16, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-february-16-2024